Skip to nav Skip to content

Antimicrobial Resistance

Facebook Twitter LinkedIn Email

Antimicrobial resistance refers to microbes’ ability to change and become less susceptible to drugs. The development of antimicrobial drugs (antibacterials [antibiotics], antivirals, antifungals and antiparasitics) to treat otherwise life-threatening infections has been one of the most notable medical achievements in human history. The growing problem of resistance has undermined antimicrobials’ effectiveness resulting in the loss of countless lives and placing public health and national security at serious risk. IDSA is working on several policy fronts to counter these “bad bugs” and to save lives.

If you or a loved one have been devastated by an antibiotic resistant bacterial infection and you would like to share your story, please contact Jennifer Morales.

Antimicrobial Stewardship

Antimicrobial stewardship refers to coordinated interventions designed to improve and measure the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration. IDSA supports broad implementation of antimicrobial stewardship programs across all health care settings (e.g., hospitals, long-term care facilities, long-term acute care facilities, ambulatory surgical centers, dialysis centers, and private practices.

Strengthening U.S. Efforts

IDSA supports legislative and administrative efforts to strengthen the U.S. response to antimicrobial resistance including through enhanced coordination and leadership, surveillance, prevention and control, and research efforts.

Antibiotic Development: The 10 x '20 Initiative

New antibiotics are desperately needed to save patients' lives, but few new drugs are in pharmaceutical companies' research and development (R&D) pipelines. IDSA is working to counter this decline through the 10 x '20 Initiative, which seeks a global commitment to create an antibiotic R&D enterprise powerful enough to produce 10 new systemic antibiotics by the year 2020.

Ending Non-Judicious Use of Antibiotics in Agriculture

Infectious diseases physicians, public health experts and others are greatly concerned about non-judicious uses of antibiotics in agriculture and particularly in food animals. A large and compelling body of scientific evidence demonstrates that antibiotic use in agriculture contributes to the emergence of resistant bacteria and their spread to humans.

Faces of Antimicrobial Resistance: The Human Cost of Antimicrobial Resistance

Many patients and their families have suffered the debilitating effects of antibiotic-resistant infections, and more and more patients are losing their lives due to these infections. These compelling and heart-wrenching stories engender a strong sense of urgency to address drug-resistant infections and the lack of new antibiotic development.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.